A novel vaccine that targets tumor vessels as an efficient tool in tumor therapy

Details for Australian Patent Application No. 2010332327 (hide)

Owner Theravac Pharmaceuticals AB

Inventors Olsson, Anna-Karin; Hellman, Lars

Agent Freehills

Pub. Number AU-A-2010332327

PCT Pub. Number WO2011/075035

Priority 0901565-2 15.12.09 SE

Filing date 15 December 2010

Wipo publication date 23 June 2011

International Classifications

A61K 39/385 Medicinal preparations containing antigens or antibodies - Haptens or antigens, bound to carriers

A61K 38/17 Medicinal preparations containing peptides - from animals

A61P 35/00 Antineoplastic agents

Event Publications

5 July 2012 PCT application entered the National Phase

  PCT publication WO2011/075035 Priority application(s): WO2011/075035

12 July 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 14 Jun 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010332339-Driver assistance

2010332294-Biogasification of coal to methane and other useful products